Literature DB >> 19794078

Defective ribosome biogenesis in myelodysplastic syndromes.

Naomi Galili, Samir Ahmed Qasim, Azra Raza.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19794078      PMCID： PMC2754946          DOI： 10.3324/haematol.2009.012021

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  22 in total

1.  Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome.

Authors:  Jacqueline Boultwood; Carrie Fidler; Amanda J Strickson; Fiona Watkins; Susana Gama; Lyndal Kearney; Sabrina Tosi; Arek Kasprzyk; Jan-Fang Cheng; Rina J Jaju; James S Wainscoat
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

2.  Mutations in SBDS are associated with Shwachman-Diamond syndrome.

Authors:  Graeme R B Boocock; Jodi A Morrison; Maja Popovic; Nicole Richards; Lynda Ellis; Peter R Durie; Johanna M Rommens
Journal:  Nat Genet       Date:  2002-12-23       Impact factor: 38.330

3.  Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia.

Authors:  M Ridanpää; H van Eenennaam; K Pelin; R Chadwick; C Johnson; B Yuan; W vanVenrooij; G Pruijn; R Salmela; S Rockas; O Mäkitie; I Kaitila; A de la Chapelle
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

4.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

Authors:  N L Harris; E S Jaffe; J Diebold; G Flandrin; H K Muller-Hermelink; J Vardiman; T A Lister; C D Bloomfield
Journal:  J Clin Oncol       Date:  1999-12       Impact factor: 44.544

5.  In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.

Authors:  Yann-Erick Claessens; Didier Bouscary; Jean-Michel Dupont; Françoise Picard; Josiane Melle; Sylvie Gisselbrecht; Catherine Lacombe; François Dreyfus; Patrick Mayeux; Michaëla Fontenay-Roupie
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

6.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

7.  Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survival.

Authors:  Akos Czibere; Ingmar Bruns; Bärbel Junge; Raminder Singh; Guido Kobbe; Rainer Haas; Ulrich Germing
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

8.  Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes.

Authors:  A Raza; S Gezer; S Mundle; X Z Gao; S Alvi; R Borok; S Rifkin; A Iftikhar; V Shetty; A Parcharidou
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

Review 9.  Apoptosis in myelodysplasia: a paradox or paradigm.

Authors:  Y Yoshida; N Anzai; H Kawabata
Journal:  Leuk Res       Date:  1995-12       Impact factor: 3.156

10.  Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis.

Authors:  A Raza; S Mundle; A Iftikhar; S Gregory; B Marcus; Z Khan; S Alvi; V Shetty; S Dameron; V Wright
Journal:  Am J Hematol       Date:  1995-03       Impact factor: 10.047
View more
  3 in total

1.  Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche.

Authors:  Sherif Abdelhamed; John T Butler; Ben Doron; Amber Halse; Eneida Nemecek; Phillip A Wilmarth; Daniel L Marks; Bill H Chang; Terzah Horton; Peter Kurre
Journal:  EMBO Rep       Date:  2019-06-17       Impact factor: 8.807

2.  Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.

Authors:  Oxana Bereshchenko; Oriana Lo Re; Fedor Nikulenkov; Sara Flamini; Jana Kotaskova; Tommaso Mazza; Marguerite-Marie Le Pannérer; Marcus Buschbeck; Cesarina Giallongo; Giuseppe Palumbo; Giovanni Li Volti; Valerio Pazienza; Libor Cervinek; Carlo Riccardi; Lumir Krejci; Sarka Pospisilova; A Francis Stewart; Manlio Vinciguerra
Journal:  Clin Epigenetics       Date:  2019-08-22       Impact factor: 6.551

3.  Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice.

Authors:  Cristian Garcia-Ruiz; Cristina Martínez-Valiente; Lourdes Cordón; Alessandro Liquori; Raúl Fernández-González; Eva Pericuesta; Juan Sandoval; José Cervera; Alfonso Gutiérrez-Adán; Alejandra Sanjuan-Pla
Journal:  Leukemia       Date:  2022-08-27       Impact factor: 12.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.